Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 22, Issue 3, pp. 553-559
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 19, 2015
- Revision received June 5, 2015
- Accepted August 9, 2015
- Published first August 31, 2015.
Article Versions
- Previous version (August 31, 2015 - 11:49).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Anne Eaton1,
- Alexia Iasonos1,2,
- Mrinal M. Gounder2,3,
- Erika G. Pamer3,
- Alexander Drilon2,3,
- Diana Vulih4,
- Gary L. Smith5,
- S. Percy Ivy5,
- David R. Spriggs2,3, and
- David M. Hyman2,3,*
- 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
- 2Weill Cornell Medical College, New York, New York.
- 3Developmental Therapeutics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
- 4Theradex Systems, Inc., Princeton, New Jersey.
- 5The National Cancer Institute, Bethesda, Maryland.
- ↵*Corresponding Author:
David M. Hyman, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. Phone: 646-888-4544; Fax: 646-888-4586; E-mail: hymand{at}mskcc.org
February 2016
Volume 22, Issue 3
Volume 22, Issue 3
Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities
Jump to section
Advertisement